Quality of life in good prognosis patients with metastatic germ cell cancer: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)

Journal of Clinical Oncology

Volumn 21, Issue 6, 2003, Pages 1107-1118

  Fosså, Sophie D ^a   De Wit, Ronald ^a   Roberts, J Trevor ^a   Wilkinson, Peter M ^a   De Mulder, Pieter H M ^a   Mead, Graham M ^a   Cook, Pat ^a   De Prijck, Linda ^a   Stenning, Sally ^a   Aaronson, Neil K ^a   Bottomley, Andrew ^a   Collette, Laurence ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RESEARCH; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL TOXICITY; GERM CELL TUMOR; HEARING IMPAIRMENT; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MULTIPLE CYCLE TREATMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RAYNAUD PHENOMENON; TESTIS CANCER; TINNITUS; ADOLESCENT; ADULT; DAILY LIFE ACTIVITY; DIGESTIVE SYSTEM; DRUG ADMINISTRATION; DRUG EFFECT; EMOTION; EUROPE; HEALTH STATUS; MALE; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT; ROLE PLAYING; SURVIVAL; TESTIS TUMOR; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; DIGESTIVE SYSTEM; DRUG ADMINISTRATION SCHEDULE; EMOTIONS; ETOPOSIDE; EUROPE; GERMINOMA; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; ROLE; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 0037445185     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.02.075     Document Type: Article

References (31)

1. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
2. de-Haes JC, van-Knippenberg FC, Neijt JP: Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62:1034-1038, 1990
3. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
4. Fosså S, Slee PHTh, Brausi M, et al: Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: A phase III study of the European Organization for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol 19:62-71, 2001
5. Bailey AJ, Parmar MK, Stephens RJ: Patient-reported short-term and long-term physical and psychologic symptoms: Results of the continuous hyperfractionated accelerated radiotherapy (CHART) randomized trial in non-small-cell lung cancer-CHART Steering Committee. J Clin Oncol 16:3082-3093, 1998
6. Gotay CC, Muraoka MY: Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst 90:656-667, 1998
7. Bloom JR, Fobair P, Gritz E, et al: Psychosocial outcomes of cancer: A comparative analysis of Hodgkin's disease and testicular cancer. J Clin Oncol 11:979-988, 1993
8. Ozen H, Sahin A, Toklu C, et al: Psychosocial adjustment after testicular cancer treatment. J Urol 159:1947-1950, 1998
9. Jonker-Pool G, van-Basten JP, Hoekstra HJ, et al: Sexual functioning after treatment for testicular cancer: Comparison of treatment modalities. Cancer 80:454-464, 1997
10. Rudberg L, Nilsson S, Wikblad K: Health-related quality of life in survivors of testicular cancer 3 to 13 years after treatment. J Psychosocial Oncol 18:19-31, 2000
11. Hannah MT, Gritz ER, Wellisch DK, et al: Changes in marital and sexual functioning in long-term survivors and their spouses: Testicular cancer versus Hodgkin's disease. Psycho-Oncol 1:89-103, 1992
12. Gritz ER, Wellisch DK, Wang HJ, et al: Long-term effects of testicular cancer on sexual functioning in married couples. Cancer 64:1560-1567, 1989
13. Gritz ER, Wellisch DK, Landsverk JA: Psychosocial sequelae in long-term survivors of testicular cancer. J Psycho Oncol 6:41-63, 1988
14. Joly F, Heron JF, Kalusinski L, et al: Quality of life in long-term survivors of testicular cancer: A population-based case-control study. J Clin Oncol 20:73-80, 2002
15. Weissbach L, Bussar-Maatz R, Flechtner H, Pichlmeier et al: RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment. Eur Urol 37:582-594, 2000
16. De Wit R, Roberts T, Wilkinson P, et al: Equivalence of three or four cycles of bleomycin, etoposide and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol 19:1629-1640, 2001
17. International Germ Cell Cancer Collaborative Group: International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594-603, 1997
18. Fossa SD, Moynihan C, Serbouti S: Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I: A descriptive pilot study. Support Care Cancer 4:118-128, 1996
19. Sprangers MA, Cull A, Bjordal K, et al: The European Organization for Research and Treatment of Cancer: Approach to quality of life assessment-Guidelines for developing questionnaire modules, EORTC Study Group on Quality of Life. Qual Life Res 2:287-295, 1993
20. Osoba D, Rodrigues G, Myles J, et al: Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139-144, 1998
21. Kaasa S, Aass N, Mastekaasa A, et al: Psychosocial well-being in testicular cancer patients. Eur J Cancer 27:1091-1095, 1991
22. Arai Y, Kawakita M, Hida S, et al: Psychosocial aspects in long-term survivors of testicular cancer. J Urol 155:574-578, 1996
23. Aass N, Kaasa S, Lund E, Kaalhus et al: Long-term somatic side-effects and morbidity in testicular cancer patients. Br J Cancer 61:151-155, 1990
24. Bokemeyer C, Berger CC, Kuczyk MA, et al: Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 14:2923-2932, 1996
25. Dolven Jacobsen K, Ous S, Wæhre H, et al: Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer 80:249-255, 1999
26. Grossfeld GD, Small EJ: Long-term side effects of treatment for testis cancer. Urol Clin North Am 25:503-515, 1998
27. Hilkens PH, ven-den-Bent MJ: Chemotherapy-induced peripheral neuropathy. J Peripher Nerv Syst 2:350-361, 1997
28. Vermorken JB, Kapteijn TS, Hart AA, et al: Ototoxicity of cis-diamminedichloroplatinum (II): Influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol 19:53-58, 1983
29. Moroso MJ, Blair RL: A review of cis-platinum ototoxicity. J Otolaryngol 12:365-369, 1983
30. Schagen SB, Muller MJ, Boogerd W, et al: Late effects of adjuvant chemotherapy on cognitive function: A follow-up study in breast cancer patients. Ann Oncol 13:1387-1397, 2002
31. Langendijk JA, ten-Velde GP, Aaronson NK, et al: Quality of life after palliative radiotherapy in non-small cell lung cancer: A prospective study. Int J Radiat Oncol Biol Phys 47:149-155, 2000